IP Library › Granted Patent US 11,786,872
Granted Patent B2
US 11,786,872 · App. 16/864,619 · Granted Oct 17, 2023

Vitro evolution in microfluidic systems

Inventors: Andrew David Griffiths (Strasbourg, FR); David A. Weitz (Cambridge, MA); Darren Roy Link (Lexington, MA); Keunho Ahn (Boston, MA); Jerome Bibette (Paris, FR)
Assignees: UNITED KINGDOM RESEARCH AND INNOVATION; PRESIDENT AND FELLOWS OF HARVARD COLLEGE
B01F23/41B01F25/433B01F25/4331B01F25/4338B01F33/3011B01F33/3021B01F33/3031B01J19/0046B01L3/502746B01L3/502753B01L3/502776B01L3/502784C12N15/1058C12N15/1075C12P21/00C12Q1/6874G01N15/1459G01N15/1484B01J2219/005B01J2219/0052B01J2219/00466B01J2219/00468B01J2219/00545B01J2219/00576B01J2219/00657B01J2219/00722B01L2200/0636B01L2200/0673B01L2300/0654B01L2300/0816B01L2300/0864B01L2300/0867B01L2400/0415B01L2400/0487G01N2015/149
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,786,872
App. No.
16/864,619
Granted
Oct 17, 2023
Kind
B2
Abstract

The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of: (a) compartmentalising genetic elements into microcapsules; and (b) sorting the genetic elements which express the gene product having the desired activity; wherein at least one step is under microfluidic control. The invention enables the in vitro evolution of nucleic acids and proteins by repeated mutagenesis and iterative applications of the method of the invention.

Claims (22)

1. A method for analyzing compounds, the method comprising:

forming a plurality of aqueous microcapsules under microfluidic control in oil, wherein each aqueous microcapsule comprises a genetic element and a cell;

incubating the plurality of aqueous microcapsules to cause the genetic element to interact with a molecule associated with the cell;

conducting an enzymatic reaction involving the molecule associated with the cell in the presence of the genetic element or a product encoded by the genetic element within one or more of the aqueous microcapsules to produce reaction products corresponding to individual gene products or genetic elements;

without first sorting the aqueous microcapsules, breaking the plurality of aqueous microcapsules to pool the contents of the plurality of microcapsules comprising reaction products in a common compartment; and

analyzing the individual genetic elements identified based on detection of a selectable change caused by the reaction products in one or more of the aqueous microcapsules.

2. The method of claim 1 , wherein the plurality of aqueous microcapsules are unable to fuse or coalesce due to the presence of a surfactant.

3. The method of claim 1 , wherein the selectable change comprises an optical signal.

4. The method of claim 1 , wherein the genetic element comprises one or more primer sequences for amplification.

5. The method of claim 1 , wherein the genetic element is attached to a bead.

6. The method of claim 1 , wherein the molecule is a reporter protein.

7. The method of claim 1 , wherein the molecule comprises a gene.

8. The method of claim 7 , further comprising expressing the gene to form a gene product.

9. The method of claim 8 , wherein the gene product is a protein.

10. The method of claim 9 , wherein the protein is an antibody.

11. The method of claim 9 , wherein the protein is located within the cell.

12. The method of claim 9 , wherein the protein is located outside of the cell.

13. The method of claim 9 , wherein the gene product is cDNA.

14. The method of claim 1 , wherein the molecule is DNA or RNA.

15. The method of claim 14 , wherein the detecting step comprises performing a sequencing reaction.

16. The method of claim 1 , wherein the enzymatic reaction comprises performing an amplification reaction.

17. The method off claim 16 , wherein the amplification reaction is a polymerase chain reaction (PCR).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2020
From: LINK, DARREN; AHN, KEUNHO; WEITZ, DAVID; BIBETTE, JEROME
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 052583/0547 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2020
From: GRIFFITHS, ANDREW
To: MEDICAL RESEARCH COUNCIL
Reel/Frame 052583/0663 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2020
From: MEDICAL RESEARCH COUNCIL
To: UNITED KINGDOM RESEARCH AND INNOVATION
Reel/Frame 052584/0001 →
Continuity (8)
Continuation 15912033 · Mar 5, 2018
Continuation 15588210 · May 5, 2017
Continuation 15587026 · May 4, 2017
Continuation 15012209 · Feb 1, 2016
Continuation 13705833 · Dec 5, 2012
Continuation 11665030
Continuation 10961695 · Oct 8, 2004
Related Publication 20200254400A1 · Aug 13, 2020